Valcare Medical (Valcare) is a provider of innovative minimally invasive technologies for the treatment of mitral regurgitation. The company's products include mitral valve repair and replacement device. It markets its products under AMEND. The company's product is designed to provide a surgical-style repair using a transcatheter technique. Valcare's products are used in the medical industry in the treatment of mitral regurgitation, a condition that affects the heart's mitral valve. Valcare is headquartered in Herzliya, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Valcare Medical
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Valcare Medical Company Overview
- Valcare Medical Company Snapshot
- Valcare Medical Pipeline Products and Ongoing Clinical Trials Overview
- Valcare Medical - Pipeline Analysis Overview
- Valcare Medical - Key Facts
- Valcare Medical - Major Products and Services
- Valcare Medical Pipeline Products by Development Stage
- Valcare Medical Ongoing Clinical Trials by Trial Status
- Valcare Medical Pipeline Products Overview
- Amend Mitral Valve Repair System
- Amend Mitral Valve Repair System Product Overview
- Amend Mitral Valve Repair System Clinical Trial
- Corona
- Corona Product Overview
- Helios
- Helios Product Overview
- Trivid
- Trivid Product Overview
- Valcare Medical - Key Competitors
- Valcare Medical - Key Employees
- Valcare Medical - Locations And Subsidiaries
- Head Office
- Recent Developments
- Valcare Medical, Recent Developments
- Jul 25, 2024: Valcare Medical Expands Amend TS EU Pilot Study to Italy
- May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study
- Jul 30, 2021: CardioFlow Medtech makes follow-on investment in transcatheter valve start-up Valcare
- Jan 27, 2021: Valcare Medical announces first-in-human transseptal implant of the AMEND Annuloplasty Ring for mitral valve repair
- Jun 20, 2016: Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend Catheter Delivered Annuloplasty Ring
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Valcare Medical Pipeline Products and Ongoing Clinical Trials Overview
- Valcare Medical Pipeline Products by Equipment Type
- Valcare Medical Pipeline Products by Indication
- Valcare Medical Ongoing Clinical Trials by Trial Status
- Valcare Medical, Key Facts
- Valcare Medical, Major Products and Services
- Valcare Medical Number of Pipeline Products by Development Stage
- Valcare Medical Pipeline Products Summary by Development Stage
- Valcare Medical Ongoing Clinical Trials by Trial Status
- Valcare Medical Ongoing Clinical Trials Summary
- Amend Mitral Valve Repair System - Product Status
- Amend Mitral Valve Repair System - Product Description
- Amend Mitral Valve Repair System - Study To Evaluate the Safety and Performance of the AMEND Trans-septal System for the Treatment of Mitral Regurgitation: AMEND TS European Pilot Study
- Corona - Product Status
- Corona - Product Description
- Helios - Product Status
- Helios - Product Description
- Trivid - Product Status
- Trivid - Product Description
- Valcare Medical, Key Employees
- Glossary
- Valcare Medical Pipeline Products by Equipment Type
- Valcare Medical Pipeline Products by Development Stage
- Valcare Medical Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- LuSeed Vascular
- Cardiovalve Ltd
- Laminate Medical Technologies Ltd
- Restore Medical Ltd
- Odem Medical Ltd
